Kinetic Analysis of (18)F-Fluoride PET Images of Breast Cancer Bone Metastases

per Doot, Robert K., Muzi, Mark, Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Mankoff, David A.
Publicat 2010

Factors influencing the uptake of (18)F-Fluoroestradiol (FES) in patients with estrogen receptor positive (ER+) breast cancer

per Peterson, Lanell M, Kurland, Brenda F, Link, Jeanne M, Schubert, Erin K, Stekhova, Svetlana, Linden, Hannah M, Mankoff, David A
Publicat 2011

Dynamic and Static Approaches to Quantifying (18)F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF

per Doot, Robert K., Dunnwald, Lisa K., Schubert, Erin K., Muzi, Mark, Peterson, Lanell M., Kinahan, Paul E., Kurland, Brenda F., Mankoff, David A.
Publicat 2007

Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: (18)F-Fluoroestradiol PET Imaging Shows Return of ER Expression

per Currin, Erin, Peterson, Lanell M., Schubert, Erin K., Link, Jeanne M., Krohn, Kenneth A., Livingston, Robert B., Mankoff, David A., Linden, Hannah M.
Publicat a J Natl Compr Canc Netw (2016)

METABOLIC AND VASCULAR FEATURES OF DYNAMIC CONTRAST ENHANCED BREAST MRI AND (15)O-WATER PET BLOOD FLOW IN BREAST CANCER

per Eby, Peter R., Partridge, Savannah C., White, Steven W., Doot, Robert K., Dunnwald, Lisa K., Schubert, Erin K., Kurland, Brenda F., Lehman, Constance D., Mankoff, David A.
Publicat 2008

Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by (18)F-Fluoroestradiol PET

per Kurland, Brenda F., Peterson, Lanell M., Lee, Jean H., Linden, Hannah M., Schubert, Erin K., Dunnwald, Lisa K., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A.
Publicat 2011

Estrogen receptor binding (FES PET) and glycolytic activity (FDG PET) predict progression-free survival on endocrine therapy in patients with ER+ breast cancer

per Kurland, Brenda F., Peterson, Lanell M., Lee, Jean H., Schubert, Erin K., Currin, Erin R., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A., Linden, Hannah M.
Publicat a Clin Cancer Res (2016)

PennPET Explorer: Human Imaging on a Whole-Body Imager

per Pantel, Austin R., Viswanath, Varsha, Daube-Witherspoon, Margaret E., Dubroff, Jacob G., Muehllehner, Gerd, Parma, Michael J., Pryma, Daniel A., Schubert, Erin K., Mankoff, David A., Karp, Joel S.
Publicat a J Nucl Med (2020)

Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients

per Kurland, Brenda F, Gadi, Vijayakrishna K, Specht, Jennifer M, Allison, Kimberly H, Livingston, Robert B, Rodler, Eve T, Peterson, Lanell M, Schubert, Erin K, Chai, Xiaoyu, Mankoff, David A, Linden, Hannah M
Publicat 2012

Association Between Serial Dynamic Contrast-Enhanced MRI and Dynamic (18)F-FDG PET Measures in Patients undergoing Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

per Partridge, Savannah C., Vanantwerp, Risa K., Doot, Robert K., Chai, Xiaoyu, Kurland, Brenda F., Eby, Peter R., Specht, Jennifer M., Dunnwald, Lisa K., Schubert, Erin K., Lehman, Constance D., Mankoff, David A.
Publicat 2010

A Phase 2 Study of 16α-[(18)F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)

per Peterson, Lanell M., Kurland, Brenda F., Schubert, Erin K., Link, Jeanne M., Gadi, V.K., Specht, Jennifer M., Eary, Janet F., Porter, Peggy, Shankar, Lalitha K., Mankoff, David A., Linden, Hannah M.
Publicat 2013

Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [(18)F]fluortriopride

per Doot, Robert K., Dubroff, Jacob G., Scheuermann, Joshua S., Labban, Kyle J., Cai, Jenny, Hsieh, Chia-Ju, Li, Shihong, Lee, Hsiaoju, Schubert, Erin K., Hou, Catherine, Sheffer, Regan, Schmitz, Alexander, Xu, Kuiying, Mach, Robert H.
Publicat a EJNMMI Phys (2018)

PET TUMOR METABOLISM IN LOCALLY ADVANCED BREAST CANCER PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY: VALUE OF STATIC VS KINETIC MEASURES OF FLUORODEOXYGLUCOSE UPTAKE

per Dunnwald, Lisa K., Doot, Robert K., Specht, Jennifer M., Gralow, Julie R., Ellis, Georgiana K., Livingston, Robert B., Linden, Hannah M., Gadi, Vijayakrishna K., Kurland, Brenda F., Schubert, Erin K., Muzi, Mark, Mankoff, David A.
Publicat 2011

Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

per Dunnwald, Lisa K., Gralow, Julie R., Ellis, Georgiana K., Livingston, Robert B., Linden, Hannah M., Specht, Jennifer M., Doot, Robert K., Lawton, Thomas J., Barlow, William E., Kurland, Brenda F., Schubert, Erin K., Mankoff, David A.
Publicat 2008

Tumor Metabolism and Blood Flow as Assessed by PET Varies by Tumor Subtype in Locally Advanced Breast Cancer

per Specht, Jennifer M., Kurland, Brenda F., Montgomery, Susan K., Dunnwald, Lisa K., Doot, Robert K., Gralow, Julie R., Ellis, Georgina K., Linden, Hannah M., Livingston, Robert B., Allison, Kimberly H., Schubert, Erin K., Mankoff, David A.
Publicat 2010

Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Bre...

per Linden, Hannah M., Kurland, Brenda F., Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Ellis, Georgiana K., Lawton, Thomas, Livingston, Robert B., Petra, Philip H., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A.
Publicat 2011

Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [(68)Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human...

per Doot, Robert K., Young, Anthony J., Daube-Witherspoon, Margaret E., Alexoff, David, Labban, Kyle J., Lee, Hwan, Wu, Zehui, Zha, Zhihao, Choi, Seok R., Ploessl, Karl H., Schubert, Erin K., Lee, Hsiaoju, Zhu, Lin, Reddin, Janet S., Karp, Joel S., Kung, Hank, Pryma, Daniel A.
Publicat a Nucl Med Biol (2020)

Breast Cancer (18)F-ISO-1 Uptake as a Marker of Proliferation Status

per McDonald, Elizabeth S., Doot, Robert K., Young, Anthony J., Schubert, Erin K., Tchou, Julia, Pryma, Daniel A., Farwell, Michael D., Nayak, Anupma, Ziober, Amy, Feldman, Michael D., DeMichele, Angela, Clark, Amy S., Shah, Payal D., Lee, Hsiaoju, Carlin, Sean D., Mach, Robert H., Mankoff, David A.
Publicat a J Nucl Med (2020)